Physician profile
Johnathan P Doolittle
NPI 1144607508
$7,012.04
in general payments reported to CMS, 2019-2025
14 companies · $852 in 2025
The $852 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $1,467 · 2021: $685 · 2022: $2,355 · 2023: $558 · 2024: $916 · 2025: $852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,325.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $4,918.55 | 2020-2025 | Titan |
| Boston Scientific Corporation | $1,370.72 | 2019-2025 | Ams 700, Ams 700 Cxr Rte Kit, Rezum Generator |
| Ferring Pharmaceuticals INC. | $372.73 | 2023-2025 | Menopur |
| Antares Pharma, INC. | $82.92 | 2024 | Xyosted |
| Teleflex LLC | $54.82 | 2025 | Barrigel |
| Sumitomo Pharma America, INC. | $51.75 | 2024-2025 | Gemtesa |
| Axonics, INC. | $26.68 | 2023 | Axonics |
| Tolmar, INC. | $25.96 | 2023 | |
| Endo USA, INC. | $24.09 | 2024 | Xiaflex |
| Civco Medical Instruments | $24.02 | 2024 | |
| Endo Pharmaceuticals INC. | $17.10 | 2022 | |
| Halozyme INC | $16.34 | 2023 | |
| Azurity Pharmaceuticals, INC. | $14.09 | 2025 | Azmiro |
| Medtronic, INC. | $12.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnathan Doolittle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.